High-dose vitamin C treatment reduces capillary leakage after burn plasma transfer in rats.
Oxidative stress after burn injuries leads to systemic capillary leakage and leukocyte activation. This study evaluates whether antioxidative treatment with high-dose vitamin C leads to burn edema reduction and prevention of leukocyte activation after burn plasma transfer. Donor rats underwent a burn (n = 7; 100 degrees C water, 12 seconds, 30% body surface area) or sham burn (37 degrees C water; n = 2) procedure and were killed after 4 hours for plasma harvest. This plasma was administered to study rats (continuous infusion). Rats were randomized to four groups (n = 8 each; burn plasma alone [BP]; burn plasma/vitamin C-bolus 66 mg/kg and maintenance dose 33 mg/kg/hr [VC66]; burn plasma/vitamin C-bolus 33 mg/kg and maintenance dose 17.5 mg/kg/hr [VC33]; and sham burn plasma [SB]). Intravital fluorescence microscopy in the mesentery was performed at 0, 60, and 120 minutes for microhemodynamic parameters, leukocyte adherence, and fluorescein isothiocyanate-albumin extravasation. No differences were observed in microhemodynamics at any time. Burn plasma induced capillary leakage, which was significantly higher compared with sham burn controls (P < .001). VC66 treatment reduced microvascular barrier dysfunction to sham burn levels, whereas VC33 had no significant effect. Leukocyte sticking increased after burn plasma infusion, which was not found for sham burn. Vitamin C treatment did not influence leukocyte activation (P > .05). Burn plasma transfer leads to systemic capillary leakage. High-dose vitamin C treatment (bolus 66 mg/kg and maintenance dose 33 mg/kg/hr) reduces endothelial damage to sham burn levels, whereas half the dose is inefficient. Leukocyte activation is not influenced by antioxidative treatment. Therefore, capillary leakage seems to be independent from leukocyte-endothelial interactions after burn plasma transfer. High-dose vitamin C should be considered for parenteral treatment in every burn patient.
Kremer
Thomas
T
Department of Hand, Plastic and Reconstructive Surgery, Burn Center-BG Trauma Center Ludwigshafen, Plastic- and Hand Surgery, University of Heidelberg, Ludwigshafen, Germany.
Harenberg
Patrick
P
Hernekamp
Frederick
F
Riedel
Katrin
K
Gebhardt
Martha M
MM
Germann
Guenter
G
Heitmann
Christoph
C
Walther
Andreas
A
D000418:Albumins; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D001830:Body Surface Area; D002056:Burns / Q000097:blood / Q000150:complications*; D019559:Capillary Leak Syndrome / Q000188:drug therapy* / Q000209:etiology; D002199:Capillary Permeability / Q000187:drug effects*; D004487:Edema / Q000209:etiology; D004730:Endothelium, Vascular / Q000187:drug effects; D017879:Isothiocyanates; D008297:Male; D008643:Mesentery / Q000098:blood supply; D008856:Microscopy, Fluorescence; D055806:Microvessels / Q000187:drug effects; D018384:Oxidative Stress; D010949:Plasma; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow
D000418:Albumins; D000975:Antioxidants; D017879:Isothiocyanates; C037152:isothiocyanic acid; D001205:Ascorbic Acid